A
A. Blythe Ryerson
Researcher at Centers for Disease Control and Prevention
Publications - 53
Citations - 5633
A. Blythe Ryerson is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 23, co-authored 50 publications receiving 4369 citations. Previous affiliations of A. Blythe Ryerson include Temple University & Emory University.
Papers
More filters
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler,Recinda L. Sherman,Nadia Howlader,Ahmedin Jemal,A. Blythe Ryerson,Kevin A. Henry,Francis P. Boscoe,Kathleen A. Cronin,Andrew C Lake,Anne-Michelle Noone,S. Jane Henley,Christie R. Eheman,Robert N. Anderson,Lynne Penberthy +13 more
TL;DR: Breast cancer subtype analysis confirms the capacity of cancer registries to adjust national collection standards to produce clinically relevant data based on evolving medical knowledge.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.
Ahmedin Jemal,Elizabeth Ward,Christopher J. Johnson,Kathleen A. Cronin,Jiemin Ma,A. Blythe Ryerson,Angela B. Mariotto,Andrew J. Lake,Reda J. Wilson,Recinda L. Sherman,Robert N. Anderson,S. Jane Henley,Betsy A. Kohler,Lynne Penberthy,Eric J. Feuer,Hannah K. Weir +15 more
TL;DR: Progress in reducing death rates and improving survival is limited for several cancer types, underscoring the need for intensified efforts to discover new strategies for prevention, early detection, and treatment and to apply proven preventive measures broadly and equitably.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
A. Blythe Ryerson,Christie R. Eheman,Sean F. Altekruse,John W. Ward,Ahmedin Jemal,Recinda L. Sherman,S. Jane Henley,Deborah Holtzman,Andrew C Lake,Anne-Michelle Noone,Robert N. Anderson,Jiemin Ma,Kathleen N. Ly,Kathleen A. Cronin,Lynne Penberthy,Betsy A. Kohler +15 more
TL;DR: The increasing burden of liver and intrahepatic bile duct (liver) cancers is highlighted in this annual report.
Journal ArticleDOI
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016
Megan G. Hofmeister,Elizabeth M. Rosenthal,Laurie K. Barker,Eli S. Rosenberg,Meredith A. Barranco,Eric W. Hall,Brian R. Edlin,Jonathan Mermin,John W. Ward,A. Blythe Ryerson +9 more
TL;DR: Over 2 million people in the United States had current HCV infection during 2013‐2016; compared to past estimates based on similar methodology, HCV antibody prevalence may have increased, while RNA prevalence may has decreased, likely reflecting the combination of the opioid crisis, curative treatment forHCV infection, and mortality among the HCV‐infected population.
Journal ArticleDOI
Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
A. Blythe Ryerson,Edward S. Peters,Steven S. Coughlin,Vivien W. Chen,Maura L. Gillison,Marsha E. Reichman,Xiao-Cheng Wu,Anil K. Chaturvedi,Kelly Y. Kawaoka +8 more
TL;DR: The objective of the current study was to describe the incidence rates of oropharyngeal and oral cavity cancers in the US with a focus on anatomic sites potentially associated with HPV infection.